INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect. - sprookjes - yvandenbroek - TriplyDB

INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect.

INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect.

http://www.wikidata.org/entity/Q35136043

about

Cancer stem cells and immunoresistance: clinical implications and solutions Novel therapies in small cell lung cancer Lung cancer: a classic example of tumor escape and progression while providing opportunities for immunological intervention Advances of immunotherapy in small cell lung cancer Immunomodulatory Function of the Tumor Suppressor p53 in Host Immune Response and the Tumor Microenvironment Combining immunotherapy and radiation therapy for small cell lung cancer and thymic tumors Chemoimmunotherapy.Impact of tumour volume on the potential efficacy of therapeutic vaccines.Recent advances in p53 research and cancer treatment Cellular immunotherapy as maintenance therapy prolongs the survival of the patients with small cell lung cancer.Targeting the p53 signaling pathway in cancer therapy - the promises, challenges and perils.Immunotherapy treatments for small-cell lung cancer: past, present and future.Evaluation of efficacy and safety for recombinant human adenovirus-p53 in the control of the malignant pleural effusions via thoracic perfusion.Lung cancer: Biology and treatment options.Polymeric oncolytic adenovirus for cancer gene therapy.Trial watch: Dendritic cell-based interventions for cancer therapy Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer Immunotherapy exposes cancer stem cell resistance and a new synthetic lethality Pharmacological activation of p53 in cancer cells Research progress in the treatment of small cell lung cancer.Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?Immune parameters affecting the efficacy of chemotherapeutic regimens.Neuroendocrine cancer vaccines in clinical trials.Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons?Tumor-stromal interactions in lung cancer: novel candidate targets for therapeutic intervention.Five-year update on the mouse model of orthotopic lung transplantation: Scientific uses, tricks of the trade, and tips for success.Beyond the standard of care: a review of novel immunotherapy trials for the treatment of lung cancer.Cell cycle inhibitors for the treatment of NSCLC.Key points of basic theories and clinical practice in rAd-p53 ( Gendicine ™) gene therapy for solid malignant tumors.Therapeutic targeting of tumor suppressor genes New perspective on targeting the tumor suppressor p53 pathway in the tumor microenvironment to enhance the efficacy of immunotherapy.Application of Evolutionary Principles to Cancer Therapy Cellular immunotherapy of cancer: an overview and future directions.Therapies in the pipeline for small-cell lung cancer.Epstein Barr virus Latent Membrane Protein-1 enhances dendritic cell therapy lymph node migration, activation, and IL-12 secretion.Combination of p53-DC vaccine and rAd-p53 gene therapy induced CTLs cytotoxic against p53-deleted human prostate cancer cells in vitro.MAGE-specific T cells detected directly ex-vivo correlate with complete remission in metastatic breast cancer patients after sequential immune-endocrine therapy.Safety and Efficacy in Advanced Solid Tumors of a Targeted Nanocomplex Carrying the p53 Gene Used in Combination with Docetaxel: A Phase 1b Study.Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia.Radiation and Anti-Cancer Vaccines: A Winning Combination.

P2860

Q26769757-4A66A9B8-FA25-46CB-BBDC-8C9B73FE8D59 Q26775390-BEA18BFE-B336-48A9-8730-001412ED5E70 Q26850218-904365E1-EEBD-40FA-ADE7-BDD42699B87E Q27027662-87BCB08D-3866-40B9-BB90-E02BBDF30F22 Q28071935-C53AE81C-8812-4ED3-AA8D-16375255F5DB Q33645601-03085338-6D11-4C58-9753-018CA5D82B4A Q34058792-C8D4145E-640A-40F5-AECD-673706557217 Q35027034-D9DE0C84-17DF-4E51-BA09-27E1F818BC34 Q35099531-D096FE4A-D840-48C4-B414-FC0FBF9AF6DF Q35655447-51FC6708-EE6D-48F0-B070-9D393B3A28E5 Q35795073-1375D3AA-8527-4A41-AFF2-C3A2B8A73344 Q35904003-F19D4FB2-3ED3-49D8-B892-03AF57F0C482 Q36224460-133F4ED2-5933-4675-81E6-3F700B209DD1 Q36328370-3F6E448A-8AC7-4B10-A510-65E5C89D4754 Q36344901-C9AF1931-3A76-4A4D-A038-E397CFA4F30D Q36388529-75D2EEF7-EF14-4E16-9E6D-38694B72FB49 Q36632306-7C896003-3042-4D77-A7EE-B4EEEBD3E59F Q37086890-6871CB6B-FB1A-4756-8467-FCC08E98CE7B Q37191174-B2DA48DE-D4B1-445D-9CF7-98E12203304C Q37604301-75D40465-BE21-4457-809F-2C3C967C8548 Q37800934-56F47FEA-464D-4ED0-94B7-77D02D631BA6 Q37848665-74C84E14-9904-48C5-9E04-AAE7C4B4D49D Q37892589-32559D6C-E962-4F31-8130-E607799396A4 Q37945301-471F7350-479F-465A-9267-532BE2524226 Q38016208-717A63DE-9A80-4E1B-89A6-A0A49BF30BC7 Q38023423-00379682-DEAC-471E-9B19-86C3C97F3CBA Q38072813-88339665-C16C-4405-8B61-B93C6B0138CF Q38199197-D34BFEFE-03F5-4B7C-9D3E-D32BA90B6B19 Q38286386-D3303AB3-D31F-414D-9057-F9AE1C4C5BED Q38306663-1D55CEF5-3251-4028-8280-FEAA37F95B5B Q38389967-40CAD215-0EAB-4BD9-8C35-38B7C7488FC8 Q38623060-6B074786-DD17-4BA9-8C6C-E7514B8E65D5 Q38673161-EA49CBEE-62F5-4977-B64E-CDE2796C56BB Q38871386-A965E369-5376-417A-860C-54FEA21619B7 Q40041237-4E7311AD-50C3-413E-9F4D-6CBDF565167B Q40169855-B10408AD-B479-4BEF-9568-3B3530D924E7 Q41510005-59A65219-B5A9-4F7E-BFE8-B74994BFF85C Q42367187-04FF17A0-989F-46AD-BBF9-71FC4CCED907 Q43297784-EB80936E-1029-4AA3-85CB-CE768997131F Q47547584-F28EED54-B099-4D33-AC91-085968017A14

P2860

INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect.

http://www.wikidata.org/entity/Q35136043

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

INGN-225: a dendritic cell-bas ...... enhanced chemotherapy effect.

@ast

INGN-225: a dendritic cell-bas ...... enhanced chemotherapy effect.

@en

type

label

INGN-225: a dendritic cell-bas ...... enhanced chemotherapy effect.

@ast

INGN-225: a dendritic cell-bas ...... enhanced chemotherapy effect.

@en

prefLabel

INGN-225: a dendritic cell-bas ...... enhanced chemotherapy effect.

@ast

INGN-225: a dendritic cell-bas ...... enhanced chemotherapy effect.

@en

P1433

Q35136043-63BC1212-B6F6-4B0E-94E0-C06040A32274

P1476

Q35136043-E8F72AA8-CA7F-45FF-9C8E-7956BF28944F

P2093

Q35136043-2D6AF406-04D9-419A-AB8C-BC7FE848AE28

Q35136043-605F9835-A14F-4D5D-BB75-04B00C40A8A0

Q35136043-ECE2151B-A134-411A-A085-C8C305777C1C

Q35136043-F27D8C67-BC56-4753-9849-2BC21E814C52

P2860

Q35136043-0A38EE24-F6A6-4BC6-824C-860D34298787

Q35136043-0EB2C780-F915-42B1-A608-0CEE73D4A963

Q35136043-122C5D90-639C-4892-AB94-A12BD16552CA

Q35136043-15F4E3B2-B590-43BA-B089-4EBB17990C03

Q35136043-1E78A4E6-7C60-4AFA-AF45-098AD37E7862

Q35136043-214337FB-8DBE-4151-80DB-FBA3E2A43FD4

Q35136043-2E790F25-5DEE-487B-98B7-BA8F75E6E3D0

Q35136043-2F0ED171-DA4B-47D1-908C-BBB5AD44DFFB

Q35136043-2FF2DF48-799A-4245-A845-3FF144C7EF46

Q35136043-3068E21F-EE30-450B-AD41-F59389462230

P304

Q35136043-AAD2BCBD-53D9-4F42-B6A1-204A26C42AAD

P31

Q35136043-FF688D96-B73A-4DFF-BF3D-CE08FD21AD66

P356

Q35136043-83BF9293-D26E-4514-867F-3815DBAE3553

P407

Q35136043-81951BD5-C600-485D-966F-441F3918DA56

P433

Q35136043-1A0DFAE2-DF37-473A-B2B9-74572E8B872E

P478

Q35136043-6D3F8684-7065-436E-9B5D-0321C9A5D713

P50

Q35136043-C6A6D0F9-2AD6-4127-8C44-2074C8D62425

P577

Q35136043-E4DBB83F-A39C-41B0-A7B4-01B375A62B29

P5875

Q35136043-E2DAD6C2-FECC-4A1D-8E9A-0AC3D2E75D89

P698

Q35136043-B6155712-BAB7-45BA-B5A1-86BD95D92CBF

P921

Q35136043-912D1F2B-C5A6-4B77-8484-719ADDB78584

P932

Q35136043-573841B8-8DEB-4CBA-9C99-5F2D9A3CD768

P356

14712598.2010.484801

P1433

Expert Opinion on Biological Therapy

P1476

INGN-225: a dendritic cell-bas ...... enhanced chemotherapy effect.

@en

P2093

Alberto A Chiappori

http://www.w3.org/2001/XMLSchema#string

Dmitry I Gabrilovich

http://www.w3.org/2001/XMLSchema#string

Hatem Soliman

http://www.w3.org/2001/XMLSchema#string

Scott J Antonia

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer

Cancer statistics, 2008

1-Methyl-DL-tryptophan, beta-(3-benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and beta-[3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase

Small cell lung cancer.

Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels.

Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer.

Management of small cell lung cancer: current state of the art.

Gain-of-function mutations in the tumor suppressor gene p53.

Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design.

Management of small cell lung cancer.

P304

983-991

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.2010.484801

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

William Janssen

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43344810

http://www.w3.org/2001/XMLSchema#string

P698

20420527

http://www.w3.org/2001/XMLSchema#string

P921

P932

3146364

http://www.w3.org/2001/XMLSchema#string